AMFPF
Price
$26.00
Change
+$1.00 (+4.00%)
Updated
Dec 16 closing price
MAHLY
Price
$16.07
Change
+$0.48 (+3.08%)
Updated
Dec 16 closing price
Ad is loading...

AMFPF vs MAHLY

Header iconAMFPF vs MAHLY Comparison
Open Charts AMFPF vs MAHLYBanner chart's image
Amplifon S.p.A
Price$26.00
Change+$1.00 (+4.00%)
Volume$1K
CapitalizationN/A
Medipal Holdings
Price$16.07
Change+$0.48 (+3.08%)
Volume$1.22K
CapitalizationN/A
AMFPF vs MAHLY Comparison Chart
Loading...
AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMFPF vs. MAHLY commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMFPF is a Hold and MAHLY is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (AMFPF: $26.00 vs. MAHLY: $16.08)
Brand notoriety: AMFPF and MAHLY are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: AMFPF: 437% vs. MAHLY: 126%
Market capitalization -- AMFPF: $8.23B vs. MAHLY: $3.69B
AMFPF [@Medical Distributors] is valued at $8.23B. MAHLY’s [@Medical Distributors] market capitalization is $3.69B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMFPF’s FA Score shows that 0 FA rating(s) are green whileMAHLY’s FA Score has 0 green FA rating(s).

  • AMFPF’s FA Score: 0 green, 5 red.
  • MAHLY’s FA Score: 0 green, 5 red.
According to our system of comparison, AMFPF is a better buy in the long-term than MAHLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMFPF’s TA Score shows that 3 TA indicator(s) are bullish while MAHLY’s TA Score has 3 bullish TA indicator(s).

  • AMFPF’s TA Score: 3 bullish, 3 bearish.
  • MAHLY’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, MAHLY is a better buy in the short-term than AMFPF.

Price Growth

AMFPF (@Medical Distributors) experienced а +4.01% price change this week, while MAHLY (@Medical Distributors) price change was +3.04% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +0.86%. For the same industry, the average monthly price growth was +2.51%, and the average quarterly price growth was +147.05%.

Industries' Descriptions

@Medical Distributors (+0.86% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMFPF($8.23B) has a higher market cap than MAHLY($3.69B). AMFPF has higher P/E ratio than MAHLY: AMFPF (40.21) vs MAHLY (13.48). MAHLY YTD gains are higher at: -0.740 vs. AMFPF (-6.801). MAHLY has higher annual earnings (EBITDA): 74B vs. AMFPF (520M). MAHLY has more cash in the bank: 252B vs. AMFPF (198M). AMFPF has less debt than MAHLY: AMFPF (1.58B) vs MAHLY (30B). MAHLY has higher revenues than AMFPF: MAHLY (3.35T) vs AMFPF (2.22B).
AMFPFMAHLYAMFPF / MAHLY
Capitalization8.23B3.69B223%
EBITDA520M74B1%
Gain YTD-6.801-0.740919%
P/E Ratio40.2113.48298%
Revenue2.22B3.35T0%
Total Cash198M252B0%
Total Debt1.58B30B5%
FUNDAMENTALS RATINGS
AMFPF vs MAHLY: Fundamental Ratings
AMFPF
MAHLY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
89
Overvalued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
5839
PRICE GROWTH RATING
1..100
6255
P/E GROWTH RATING
1..100
6076
SEASONALITY SCORE
1..100
5011

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMFPF's Valuation (38) in the null industry is somewhat better than the same rating for MAHLY (89). This means that AMFPF’s stock grew somewhat faster than MAHLY’s over the last 12 months.

AMFPF's Profit vs Risk Rating (95) in the null industry is in the same range as MAHLY (100). This means that AMFPF’s stock grew similarly to MAHLY’s over the last 12 months.

MAHLY's SMR Rating (39) in the null industry is in the same range as AMFPF (58). This means that MAHLY’s stock grew similarly to AMFPF’s over the last 12 months.

MAHLY's Price Growth Rating (55) in the null industry is in the same range as AMFPF (62). This means that MAHLY’s stock grew similarly to AMFPF’s over the last 12 months.

AMFPF's P/E Growth Rating (60) in the null industry is in the same range as MAHLY (76). This means that AMFPF’s stock grew similarly to MAHLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMFPFMAHLY
RSI
ODDS (%)
Bearish Trend 4 days ago
43%
Bullish Trend 4 days ago
28%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
29%
Bearish Trend 4 days ago
38%
Momentum
ODDS (%)
Bullish Trend 4 days ago
28%
Bullish Trend 4 days ago
28%
MACD
ODDS (%)
Bullish Trend 4 days ago
18%
Bullish Trend 4 days ago
25%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
25%
Bullish Trend 4 days ago
36%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
26%
Bullish Trend 4 days ago
35%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
50%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
45%
Bearish Trend 4 days ago
35%
View a ticker or compare two or three
Ad is loading...
AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLPCX15.310.18
+1.19%
JPMorgan US Large Cap Core Plus C
MRIMX22.550.26
+1.17%
Victory Integrity Mid-Cap Value R6
APGAX97.020.96
+1.00%
AB Large Cap Growth A
GTTUX55.170.48
+0.88%
Goldman Sachs Small Cp Val Insghts R6
TNYRX10.250.03
+0.29%
1290 Loomis Sayles Multi-Asset Income R

AMFPF and

Correlation & Price change

A.I.dvisor tells us that AMFPF and ZYXI have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMFPF and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMFPF
1D Price
Change %
AMFPF100%
N/A
ZYXI - AMFPF
10%
Poorly correlated
-1.79%
COSM - AMFPF
2%
Poorly correlated
-5.82%
NSVGF - AMFPF
1%
Poorly correlated
N/A
SHPMY - AMFPF
0%
Poorly correlated
N/A
MAHLY - AMFPF
0%
Poorly correlated
N/A
More

MAHLY and

Correlation & Price change

A.I.dvisor tells us that MAHLY and ZYXI have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAHLY and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAHLY
1D Price
Change %
MAHLY100%
N/A
ZYXI - MAHLY
5%
Poorly correlated
-1.79%
PDRX - MAHLY
2%
Poorly correlated
N/A
SHPMF - MAHLY
2%
Poorly correlated
N/A
ARRJF - MAHLY
2%
Poorly correlated
N/A
COSM - MAHLY
2%
Poorly correlated
-5.82%
More